White paper: The next step to automating clinical trials
Document
Temperature management is critical when it comes to ensuring patient safety in clinical development, but we continue to use legacy point solutions that require heavy manual processes and duplication of data.
However, there are new solutions that digitize manual processes, resulting in reduced site burden, timely kit level data for study teams, and ensuring safe delivery right to the patient.
What is on this page?
Click to jump to a specific section below.
Automating Clinical Trials
“You can say that if you meet all the needs of clinical you would meet all the needs of commercial, but you can’t say the inverse - you can’t say that if you meet all commercial needs, you’d satisfy all the regulatory requirements of a clinical setting.”
So argues Evan Hahn, VP of TSS North America, making the point that perhaps we’re guilty of offering similar solutions for both clinical and commercial distribution streams when their requirements - although they share certain elements - are ultimately different.
Download this white paper where Evan Hahn, VP TSS North America, Tobias Holmer CPO at TSS, and Cat Hall, VP of Clinical Innovation and Quality at Endpoint Clinical discuss how automating Clinical Trials and tight technical integrations are key to increasing the rate of successful outcomes of clinical trials, while also speeding up the whole clinical process.
You may also be interested in
Cooperation with Swedish Innovation Authority and University to Optimize Sustainability Procedures
Loggers with reusable components can decrease the carbon footprint by almost 90% compared to disposable. These important discoveries were made during a close collaboration between business, research, and authorities to prepare for more environmentally and socially sustainable business practices.
Read moreDownload Whitepaper
On time and in full, when it matters most
When TSS received the request to support Sandoz, the Novartis generics and biosimilar division, from its client Novartis, a multinational pharmaceutical company based in Switzerland, citing their need for urgent support with surveillance of critical shipments related to a COVID-19, the obvious solution was TSS Real-Time Monitoring solution.
Read moreDownload Whitepaper
Exploring the solution to a global question
When it comes to global transportation and shipping of drugs, simply knowing where they are is no longer enough. Pharmaceutical organisations are becoming increasingly aware of the safety regulations which go into storage and transportation, i.e. ensuring that every drug which reaches the patient end, is effective and safe for consumption.
Read moreDownload WhitepaperYou may also be interested in
On-demand webinar: Introducing BLE technology for temperature monitoring
Get introduced to the solution tailored to GxP critical shipments – BLE technology for temperature monitoring
Read more
TSS Receives CDP SME Climate Score 'SME B' for Strong Climate Actions
TSS, a global company specializing in temperature monitoring for the pharmaceutical supply chain, is proud to announce that it has received an 'SME B' rating from the 2024 CDP SME Climate Score. This recognition highlights TSS’s commitment to being open about its environmental impact and taking steps to reduce it.
Read more